Manchester Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Manchester Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-976	Closed	-$53K	–	604
2017 Q4	$53K	Hold	976	–	–	0.01%	341
2017 Q3	$56K	Hold	976	–	–	0.01%	327
2017 Q2	$59K	Hold	976	–	–	0.01%	331
2017 Q1	$53K	Buy	+976	New	+$48.1K	0.01%	347

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Manchester Capital Management's BIVV Position: Q1 2018 in Review

Manchester Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 976 shares — an estimated $53K sold.

Manchester Capital Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $59K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Manchester Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Manchester Capital Management sold 976 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $53K.
Manchester Capital Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Manchester Capital Management's Bioverativ Inc. Common Stock position peaked at $59K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Manchester Capital Management's 13F filing for Q1 2018, filed 7 May 2018.